The Vietnam Pharmaceuticals market size was worth USD 7.94 billion in 2024 and is estimated to grow to USD 8.58 billion in 2025 and reach USD 16.03 billion by 2032. The market is projected to grow at a CAGR of 9.33% during the forecast period.<\/p>\n
The Vietnam pharmaceuticals market is expected to witness significant growth during the forecast period. Increasing number of chronic diseases, coupled with rising aging population is leading to a growing demand for pharmaceutical products such as generic drugs, which includes prescription drugs.<\/p>\n
Furthermore, rising focus of key players to expand their footprints in the country with strategic initiatives such as collaborations, and clinical trials is propelling the market growth in the country.<\/p>\n
Additionally, presence of active government programs to increase the adoption of drugs and vaccines in the country is contributing to the market growth prospects.<\/p>\n
Request a Free sample<\/a> to learn more about this report.<\/p>\n<\/p>\n As per the WHO, Vietnam achieved remarkable progress in childhood immunization, with 95.0% reduction in the number of unvaccinated children.<\/p>\n Vietnam Pharmaceuticals Market Trends<\/strong><\/p>\n Rising Focus on Offerings Such as Specialty Medicine is a Prominent Market Trend <\/strong><\/p>\n The rising focus on targeted treatment and cell based therapy for genetic disorders, rare diseases, blood disorders, and cancers is shifting the focus of caregivers and companies on developing and launching new specialty medicines.<\/p>\n
\n<\/ul>\n To know how our report can help streamline your business, Speak to Analyst <\/a> <\/p>\n \u00a0<\/p>\n As per the study performed by the University Medical Center, Vietnam, in March 2025, the prevalence of prediabetes and undiagnosed diabetes were significantly higher among people in Vietnam.<\/p>\n
\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 In the type segmentation, drugs accounted for around 93.6% of the Vietnam pharmaceuticals market share in 2024.<\/p>\n
<\/p>\n \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 In the disease indication segmentation, oncology is projected to grow at a CAGR of 11.3% in the forecast period.<\/p>\n
<\/p>\n \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 In the drug type segmentation, biologics & biosimilars<\/a> accounted for around 40.2% of the Vietnam pharmaceuticals market in 2024.<\/p>\n
<\/p>\n \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 The Oral segment, under the route of administration segmentation, was worth USD 3.82 billion in 2024.<\/p>\n
<\/p>\n \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 In the age group segmentation, the adults segment is projected to grow at a CAGR of 9.4% in the forecast period.<\/p>\n
\n<\/td>\n
Vietnam Pharmaceuticals Market Growth Factors<\/strong><\/p>\n Increasing Strategic Activities for Expansion of Pharmaceuticals Business to Drive Market Growth<\/strong><\/p>\n In recent times, there has been increasing strategic activities between the major pharmaceutical players for broadening of the product portfolios, enhancement of technology transfer, launching of new therapeutic segments, and strengthening of distribution networks. Such factors are expected to drive the Vietnam pharmaceuticals market growth.<\/p>\n
\n<\/ul>\n Vietnam Pharmaceuticals Market Restraints<\/strong><\/p>\n Limited Public Access to New Drugs Restricts Market Growth<\/strong><\/p>\n Lengthy drug registration processes delays the market entry of new drugs and thus discourages investments from the global pharmaceutical<\/a> companies, and reduces the access of new treatments for the patients.<\/p>\n
\n<\/ul>\n Segmentation Analysis<\/strong> Strategic Collaborations to Propel Vaccine Manufacturing and Boost Segmental Growth<\/strong><\/p>\n On the basis of type segment, the market is segmented into vaccines and drugs.<\/p>\n The vaccines segment is expected to grow at the highest CAGR during the forecast period. Increasing strategic activities amongst the key players including the regional companies to expand the production capacities of vaccines in Vietnam, thus propelling the segment\u2019s growth in the market.<\/p>\n
\n<\/ul>\n By Disease Indication<\/strong><\/p>\n Rising Development Activities to Launch Drugs for Respiratory Conditions to Boost Segmental Growth<\/strong><\/p>\n Based on disease indication, the market is segmented into ophthalmic, infectious, cardiovascular, oncology, diabetes, neurology & psychiatry, hematology\/blood, liver\/hepatology, respiratory, renal, obesity, autoimmune, gastrointestinal, dermatology, genetic, hormonal\/endocrine, women\u2019s health, reproductive, allergies, and others.<\/p>\n The respiratory segment is expected to grow at a significant compound annual growth rate (CAGR) during the forecast period. Increasing prevalence of respiratory diseases and emphasis on developing new formulations for its treatment is propelling the segment\u2019s growth.<\/p>\n
\n<\/ul>\n Request a Free sample<\/a> to learn more about this report.<\/p>\n<\/p>\n As per the Global Cancer Observatory 2022 report, breast cancer is the most frequent cancer in Vietnam.<\/p>\n \u00a0By Drug Type<\/strong><\/p>\n Approval for Commercialization of Biosimilars to Propel Biologics & Biosimilars Segment\u2019s Growth<\/strong><\/p>\n On the basis of drug type, the market is segmented into small molecules\/ conventional drugs and biologics & biosimilars.<\/p>\n The biologics & biosimilars segment is expected to grow substantially during forecast period. Increasing regulatory approvals for commercialization of biosimilars in the Vietnam market is bolstering the market growth.<\/p>\n
\n<\/ul>\n By Route of Administration<\/strong><\/p>\n Launch of Novel Oral Drug Formulation to Drive Segments Growth<\/strong><\/p>\n Based on the route of administration, the market is divided into oral, parenteral, topical, inhalation, and others.<\/p>\n The oral segment is expected to hold the highest market share. \u00a0The advantages associated with the oral drugs and better treatment adherence are few factors driving the segmental growth. Additionally, launches of advanced formulations for preventive therapy also boosts the segmental growth.<\/p>\n
\n<\/ul>\n By Age Group<\/strong><\/p>\n Increasing Programs for Pediatric Immunization Propeled Segments\u2019 Growth<\/strong><\/p>\n By age group, the market is bifurcated into pediatric and adults.<\/p>\n The pediatric segment held a significant proportion of Vietnam pharmaceuticals market share in 2024. Rising risk of infectious diseases among the children and increasing number of immunization programs for them drives the segment\u2019s growth.<\/p>\n
\n<\/ul>\n
<\/p>\n
\n
<\/p>\n
<\/p>\n
\nKey takeaways<\/strong>
<\/p>\n
\n<\/tr>\n
\n
<\/p>\n
<\/p>\n
<\/p>\n
\nBy Type <\/strong><\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n